Navigation Links
NeuroSigma, Inc. Retains CCG Investor Relations
Date:4/4/2011

ry best at institutions like UCLA and bringing their pioneering work to the marketplace for commercialization.  The Company is initially focused on several very important conditions, including epilepsy, which affects 3 million people in the United States and over 50 million worldwide, and major depression, affecting over 18 million American adults and over 120 million worldwide.  With its current team and strong development processes in place, the Company is well positioned for the future."

About NeuroSigma

NeuroSigma is a Los Angeles-based medical technology company established to in-license and develop early stage technologies with the potential to transform medical practice.  Currently we have a specific focus on neuromodulation.  NeuroSigma employs two therapy platforms: Trigeminal Nerve Stimulation (TNS) and Deep Brain Stimulation (DBS).  NeuroSigma has amassed a significant intellectual property portfolio, primarily licensed from the University of California, Los Angeles on a world-wide exclusive basis, including potential therapies for epilepsy, depression and post-traumatic stress disorder (PTSD) via TNS and for PTSD, obesity and cachexia via DBS.  More information about NeuroSigma is online at http://www.neurosigma.com/

About CCG Investor Relations

CCG is a leading global investor relations and strategic communications consulting firm.  In business for more than 30 years, the agency provides a complete range of strategic and investor communications, through our global network to over 100 clients across multiple capital markets.  CCG has been awarded a number of industry honors for its handling of complex investor relations communications matters.  The agency's corporate headquarters is in Los Angeles with additional offices in New York, Beijing, Shanghai, Hong Kong, London, and Tel Aviv.  For further information, contact CCG d
'/>"/>

SOURCE NeuroSigma, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. BioDrain Medical, Inc. Retains CFSG1 as Its U.S. Investor Relations Firm
2. Dehaier Medical Retains The Piacente Group as Strategic Investor Relations Consulting Firm
3. SCOLR Pharma, Inc. Retains Nicholas Hall & Company
4. Xenogenics Corporation Retains the Emmes Group to Advise on Fund Raising Efforts
5. Independent Committee of Caraco Board Retains Independent Advisors for Consideration of Sun Pharma Proposal to Purchase Outstanding Shares and Caraco Acknowledges Filing of Purported Class Action Lawsuits
6. Lotus Pharmaceuticals Retains Sichenzia Ross Friedman Ference LLP as General Legal Counsel
7. Anadys Retains Lazard as Strategic Advisor
8. Connectyx Retains Services of CP Capital Securities as It Expands Its Presence in the $5 Billion US Electronic Health Record Market
9. China Pharma Holdings, Inc. Retains CCG Investor Relations
10. Ampio Pharmaceuticals, Inc. Retains Redwood Consultants, LLC to Assist in Shareholder Relations and Strategic Planning
11. Solos Endoscopy, Inc. Retains Expert Resource to Meet Requirements for ISO 13485 Quality Management System Initiative
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... 23, 2013 InspireMD, Inc. ... leader in embolic protection stents, today announced new ... ST Elevation Reperfusion) trial demonstrating that the MGuard ... drug eluting stents in all-cause mortality in ST ... the trial were presented at the InspireMD STEMI ...
(Date:5/23/2013)... Switzerland and DRESDEN, Germany ... Cenix BioScience, a leading preclinical contract research ... and high content-driven pharmacology, and Debiopharm Group™ (Debiopharm), ... a focus on the development of prescription drugs ... companion diagnostics, today announced that they have signed ...
(Date:5/22/2013)... Tenn. , May 22, 2013  Team Health ... of the largest suppliers of outsourced healthcare professional staffing ... in the United States , today ... 38th Annual Deutsche Bank Healthcare Conference held on May ... will begin at 8:00 AM eastern time.  Interested investors ...
Breaking Medicine Technology:InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 2InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 3InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 4InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 5Cenix BioScience and Debiopharm Group Collaborate to Identify Predictive Biomarkers 2Cenix BioScience and Debiopharm Group Collaborate to Identify Predictive Biomarkers 3Cenix BioScience and Debiopharm Group Collaborate to Identify Predictive Biomarkers 4Team Health Holdings Inc. to Present at the 38th Annual Deutsche Bank Healthcare Conference 2
... GROVE, Minn., Feb. 18, 2011 Upsher-Smith Laboratories, Inc., ... announced recall of Jantoven® Warfarin Sodium, USP, 3 mg ... the same packaging line between May 17, 2010 and ... as a precautionary measure after a single bottle labeled ...
... Chilcott plc (Nasdaq: WCRX ) today announced that ... is scheduled to speak at the Citi 2011 Global Health ...   The presentation will be simultaneously webcast ... webcast available shortly thereafter at http://ir.wcrx.com/events.cfm . ...
Cached Medicine Technology:Upsher-Smith Laboratories Announces Expansion of Voluntary Nationwide Recall 2Upsher-Smith Laboratories Announces Expansion of Voluntary Nationwide Recall 3
(Date:5/23/2013)... some fast-food chains are required to provide calorie and ... kids who eat fast food at least twice a ... information than kids who eat fast food less often, ... likely to use the calorie information are girls and ... U.S. Centers for Disease Control and Prevention. The ...
(Date:5/23/2013)... Thompson HealthDay Reporter , , THURSDAY, May 23 ... millions to lower their cholesterol, but the medications also ... health through exercise, researchers say. A small group ... any significant fitness gains while taking a 40 milligram ... the drug but undergoing the same exercise regimen did ...
(Date:5/23/2013)... patients with a liposomal formulation of anthracycline-based chemotherapy at ... in high survival rates without causing any added heart ... published online today in Blood ... Hematology (ASH). , Acute myeloid leukemia (AML), ... is a blood cancer in which the bone marrow ...
(Date:5/23/2013)... influences soldier PTSD , Soldiers returning home from ... post-traumatic stress disorder if public support for a war ... or invalidation shapes the level of distress soldiers feel ... study involved two experiments that asked participants to exterminate ... having an actor show either interest or disgust for ...
(Date:5/23/2013)... A new study determined that children and adolescents ... to have clinically significant behavioral problems and psychiatric ... , a journal published by Wiley on behalf ... the importance of routine psychiatric evaluation for pediatric ... to anti-seizure medications and require epilepsy surgery. ...
Breaking Medicine News(10 mins):Health News:Too Few Kids Use Fast-Food Calorie Info, Study Finds 2Health News:Statins May Hamper Workout Results 2Health News:Statins May Hamper Workout Results 3Health News:Improved chemo regimen for childhood leukemia may offer high survival, no added heart toxicity 2Health News:Improved chemo regimen for childhood leukemia may offer high survival, no added heart toxicity 3Health News:Link between war support and PTSD, time it late in negotiations and courtship by narcissists 2Health News:Link between war support and PTSD, time it late in negotiations and courtship by narcissists 3Health News:Depression common among children with temporal lobe epilepsy 2
... Two ... biopharmaceutical environment. , ... Horsham, PA, USA (Vocus) June 5, 2009 -- The Drug Information ... longest running global, multidisciplinary conference featuring sessions and preconference tutorials on issues affecting drug ...
... techniques and bedtime habits may ease insomnia , ... sheep, maybe even taken sleeping pills. You might also ... a better night,s rest. , Chronic insomniacs who took ... about sleep hygiene, relaxation techniques and tips for stilling ...
... 5 Cardinal Health will hold an investor and ... EDT. The sole purpose is to discuss the year-to-date ... Health and CareFusion as standalone entities. , , ... the session and will explain pro forma financials for ...
... and serum lipid levels have improved in Swedish middle-aged ... mental stress, however, have increased significantly. These are the ... of Gothenburg, Sweden. The study is part of ... This study was initiated at the end of the ...
... /PRNewswire-FirstCall/ -- NeoGenomics, Inc. (NASD OTC Bulletin ... the Fifth Annual Noble Financial Equity Conference at 9:15 ... Seminole Hard Rock Hotel in Hollywood, FL. Robert ... give a presentation regarding NeoGenomics, market positioning, financial performance, ...
... , Clearance Opens Door To Multi-Billion Dollar Home Skin ... Palomar Medical Technologies Inc. (Nasdaq: PMTI ), a ... today announced that it has become the first company to ... Food and Drug Administration (FDA) for a new, patented, home ...
Cached Medicine News:Health News:DIA 45th Annual Meeting Features Sessions Highlighting Wyeth v. Levine and Pandemic Influenza 2Health News:DIA 45th Annual Meeting Features Sessions Highlighting Wyeth v. Levine and Pandemic Influenza 3Health News:Can't Sleep? Try Online Therapy 2Health News:Cardinal Health Investor and Analyst Advisory 2Health News:Middle-aged women experience more stress but have lower blood pressure 2Health News:NeoGenomics to Present at Noble Financial's 5th Annual Equity Conference on Monday, June 8th 2Health News:Palomar Receives FDA Over-The-Counter Clearance for a Home Use Wrinkle Removal Laser Device 2Health News:Palomar Receives FDA Over-The-Counter Clearance for a Home Use Wrinkle Removal Laser Device 3Health News:Palomar Receives FDA Over-The-Counter Clearance for a Home Use Wrinkle Removal Laser Device 4
Streptavidin A-Beads are polydisperse 1.8 m paramagnetic particles covalently coupled with streptavidin. The paramagnetic particles remain in solution over extended periods of time. Mixing is require...
... method for isolating antibodies, antigens, lectins, ... affinity binding, while retaining biological activity. ... particles to separate biotinylated molecules from ... Beads from the suspension, an external ...
QuantumPlex is a bead kit for multiple analyte-detection research applications in flow cytometry. The beads may be analyzed with any standard cytometer and do not require the use of specialized softw...
... magnetic beads are 1 ... coupled to a form ... can be useful as ... including mRNA isolation and ...
Medicine Products: